Zosano Pharma (ZSAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZSAN | AMGN | GILD | CELG | BIIB |
| Company | Zosano Pharma | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5188 | 267.49 | 65.25 | 108.01 | 201.30 |
| High | 0.6350 | 267.49 | 65.25 | 108.59 | 201.30 |
| Low | 0.4600 | 267.49 | 65.25 | 107.27 | 201.30 |
| Last | 0.5576 | 267.49 | 65.25 | 108.24 | 201.30 |
| Change | +0.0376 | -1.89 | -0.02 | +0.11 | -1.16 |
| % Change | +7.23% | -0.70% | -0.03% | +0.10% | -0.57% |
| Volume | 1,155,000 | 1,640 | 3,326 | 191,230,496 | 2,179 |
| 20-Day Average Volume | 545,850 | 2,035,177 | 6,443,437 | 16,188,930 | 1,185,509 |
| Previous Close | 0.5200 | 269.38 | 65.27 | 108.13 | 202.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5001 | 269.86 | 68.28 | 108.17 | 200.75 |
| 20-Day Raw Stochastic | 5.61% | 29.32% | 1.97% | 63.25% | 45.18% |
| 20-Day Relative Strength | 25.13% | 43.14% | 28.27% | 64.69% | 42.23% |
| Weighted Alpha | -93.05 | +8.06 | -23.76 | +46.30 | -34.99 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.51% since 06/03/22 | -0.54% since 04/19/24 | -2.26% since 04/19/24 | -1.97% since 11/13/19 | +3.56% since 04/19/24 |
| Low | 0.4600 on 06/10/22 | 267.24 on 04/25/24 | 65.09 on 04/25/24 | 107.27 on 11/20/19 | 192.75 on 04/23/24 |
| High | 0.7200 on 06/06/22 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | -68.85% since 05/10/22 | -5.07% since 03/26/24 | -9.89% since 03/26/24 | +5.14% since 10/18/19 | -5.06% since 03/26/24 |
| Low | 0.4600 on 06/10/22 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 2.1993 on 05/20/22 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -90.38% since 03/10/22 | -14.20% since 01/26/24 | -17.95% since 01/26/24 | +13.63% since 08/20/19 | -17.78% since 01/26/24 |
| Low | 0.4600 on 06/10/22 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 10.0835 on 03/24/22 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -97.21% since 12/10/21 | -0.82% since 10/26/23 | -16.88% since 10/26/23 | +14.14% since 05/20/19 | -16.50% since 10/26/23 |
| Low | 0.4600 on 06/10/22 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 24.8045 on 01/05/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,734 | 144,488,960 | 81,266,176 | 77,035,920 | 29,429,788 |
| Shares Outstanding, K | 4,902 | 536,376 | 1,245,077 | 711,714 | 145,361 |
| Annual Sales | 790,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -29,930,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 130,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -33,410,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
| 60-Month Beta | 3.30 | 0.58 | 0.19 | 1.41 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -7.86 on 05/13/22 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/11/22 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 13.47 |